Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1-Reference-Cited by-同舟云学术

Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1

Published:2016-03-10 Issue:4 Volume:8 Page:761-774
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Chen Weizao,Bardhi Ariola,Feng Yang,Wang Yanping,Qi Qianqian,Li Wei,Zhu Zhongyu,Dyba Marzena A.,Ying Tianlei,Jiang Shibo,Goldstein Harris,Dimitrov Dimiter S.

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/19420862.2016.1160180

Reference32 articles.

1. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

2. Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design

3. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice

4. Exceptionally Potent and Broadly Cross-Reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains

5. sCD4-17b bifunctional protein: Extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections;Biomedicines;2022-08-02

2. Soluble trivalent engagers redirect cytolytic T cell activity toward tumor endothelial marker 1;Cell Reports Medicine;2021-08

3. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model;Cellular Immunology;2021-01

4. Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus Infection;Journal of Virology;2019-10-15

5. Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41;Viruses;2019-08-01